ME00578A - Use of gastrointestinal lipase inhibitors - Google Patents

Use of gastrointestinal lipase inhibitors

Info

Publication number
ME00578A
ME00578A MEP-903/08A MEP90308A ME00578A ME 00578 A ME00578 A ME 00578A ME P90308 A MEP90308 A ME P90308A ME 00578 A ME00578 A ME 00578A
Authority
ME
Montenegro
Prior art keywords
lipase inhibitors
gastrointestinal lipase
gastrointestinal
inhibitors
medicaments
Prior art date
Application number
MEP-903/08A
Other languages
English (en)
Croatian (hr)
Inventor
Jonathan Brian Hauptman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21894047&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ME00578(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of ME00578A publication Critical patent/ME00578A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Plant Substances (AREA)
MEP-903/08A 1997-02-05 1998-01-29 Use of gastrointestinal lipase inhibitors ME00578A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3738397P 1997-02-05 1997-02-05
PCT/EP1998/000468 WO1998034630A1 (en) 1997-02-05 1998-01-29 Use of gastrointestinal lipase inhibitors

Publications (1)

Publication Number Publication Date
ME00578A true ME00578A (en) 2011-12-20

Family

ID=21894047

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-903/08A ME00578A (en) 1997-02-05 1998-01-29 Use of gastrointestinal lipase inhibitors

Country Status (27)

Country Link
US (1) US6147108A (id)
EP (1) EP1017408B1 (id)
JP (1) JP2001509173A (id)
KR (1) KR100479968B1 (id)
CN (1) CN1154505C (id)
AR (1) AR011106A1 (id)
AT (1) ATE292975T1 (id)
AU (1) AU740375B2 (id)
BR (1) BR9807655A (id)
CA (1) CA2278854C (id)
CZ (1) CZ295567B6 (id)
DE (1) DE69829763T2 (id)
DK (1) DK1017408T3 (id)
ES (1) ES2239799T3 (id)
HU (1) HU230834B1 (id)
ID (1) ID22650A (id)
IL (1) IL131007A0 (id)
ME (1) ME00578A (id)
NO (1) NO324452B1 (id)
NZ (1) NZ336755A (id)
PL (1) PL191222B1 (id)
PT (1) PT1017408E (id)
RU (1) RU2201272C2 (id)
TR (1) TR199901853T2 (id)
WO (1) WO1998034630A1 (id)
YU (1) YU34199A (id)
ZA (1) ZA98753B (id)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9807655A (pt) * 1997-02-05 2000-02-15 Hoffmann La Roche Uso de inibidores de lipase gastrintestinal.
AR025587A1 (es) * 1999-09-13 2002-12-04 Hoffmann La Roche Formulaciones en dispersion que contienen inhibidores de lipasa
AR025609A1 (es) 1999-09-13 2002-12-04 Hoffmann La Roche Formulaciones lipidas solidas
EP1134231B1 (en) 2000-03-14 2009-04-15 Unilever N.V. Antibody heavy chain variable domains against human dietary lipases, and their uses
US7060675B2 (en) 2001-02-15 2006-06-13 Nobex Corporation Methods of treating diabetes mellitus
US6867183B2 (en) 2001-02-15 2005-03-15 Nobex Corporation Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
US6828297B2 (en) * 2001-06-04 2004-12-07 Nobex Corporation Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US7196059B2 (en) 2001-09-07 2007-03-27 Biocon Limited Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
US7053080B2 (en) * 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
AU2003236521A1 (en) 2002-06-13 2003-12-31 Nobex Corporation Methods of reducing hypoglycemic episodes in the treatment of diabetes mellitus
US9174176B2 (en) 2003-01-09 2015-11-03 Disperse Systems, Inc. Ultrasonic dispersion apparatus, system, and method
RU2248793C1 (ru) * 2003-11-13 2005-03-27 Лазебник Леонид Борисович Способ лечения стеатогепатитов
US7510849B2 (en) * 2004-01-29 2009-03-31 Glucolight Corporation OCT based method for diagnosis and therapy
CN103223160B (zh) 2004-07-19 2015-02-18 比奥孔有限公司 胰岛素-低聚物共轭物,制剂及其用途
US8036727B2 (en) 2004-08-11 2011-10-11 Glt Acquisition Corp. Methods for noninvasively measuring analyte levels in a subject
US7254429B2 (en) 2004-08-11 2007-08-07 Glucolight Corporation Method and apparatus for monitoring glucose levels in a biological tissue
EP1874178A4 (en) 2005-04-13 2009-12-09 Glucolight Corp METHOD OF DECREASING AND CALIBRATION OF DATA OF A CROSS-REFERENCE OF A BLOOD GLUCOMETER BASED ON OPTICAL COHERENCE TOMOGRAPHY AND RELATED APPLICATIONS
US8217025B2 (en) * 2006-11-17 2012-07-10 Harbor Therapeutics, Inc. Drug screening and treatment methods
ES2350798T3 (es) * 2007-09-12 2011-01-27 Mader S.R.L. Composiciones farmacéuticas para uso oral para tratar a pacientes afectados por la obesidad.
MX2010004072A (es) * 2007-10-15 2010-09-14 Inventis Dds Pvt Ltd Composicion farmaceutica de orlistat.
US9241908B2 (en) 2007-10-16 2016-01-26 Biocon Limited Orally administrable solid pharmaceutical composition and a process thereof
WO2009111542A2 (en) 2008-03-04 2009-09-11 Glucolight Corporation Methods and systems for analyte level estimation in optical coherence tomography
WO2010042499A1 (en) * 2008-10-06 2010-04-15 Banner Pharmacaps, Inc. Stable solutions of orlistat for pharmaceutical dosage forms
FR3017536B1 (fr) * 2014-02-18 2017-05-26 Univ La Rochelle Compositions pour la prevention et/ou le traitement de pathologies liees a l'alpha-glucosidase
WO2017161043A1 (en) 2016-03-16 2017-09-21 The J. David Gladstone Institutes Methods and compositions for treating obesity and/or diabetes and for identifying candidate treatment agents
WO2019018849A1 (en) * 2017-07-21 2019-01-24 Kieu Hoang STATINES (ATORVASTATIN) THAT CAN REDUCE GLYCEMIA LEVEL IN DIABETICS

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1247547A (en) * 1983-06-22 1988-12-28 Paul Hadvary Leucine derivatives
CA1270837A (en) * 1984-12-21 1990-06-26 Hoffmann-La Roche Limited Oxetanones
CA1328881C (en) * 1984-12-21 1994-04-26 Pierre Barbier Process for the manufacture of oxetanones
CA2035972C (en) * 1990-02-23 2006-07-11 Martin Karpf Process for the preparation of oxetanones
US5298497A (en) * 1990-05-15 1994-03-29 E. R. Squibb & Sons, Inc. Method for preventing onset of hypertension employing a cholesterol lowering drug
US5190970A (en) * 1990-10-19 1993-03-02 E. R. Squibb & Sons, Inc. Method for preventing onset of or treating Type II diabetes employing a cholesterol lowering drug alone or in combination with an ace inhibitor
US5130333A (en) * 1990-10-19 1992-07-14 E. R. Squibb & Sons, Inc. Method for treating type II diabetes employing a cholesterol lowering drug
US5345056A (en) * 1991-12-12 1994-09-06 Motorola, Inc. Plasma based soldering by indirect heating
CA2098167C (en) * 1992-06-24 2006-12-19 Dorothea Isler Foodstuffs and feedstuffs containing a lipase inhibitor
TW381025B (en) * 1993-08-05 2000-02-01 Hoffmann La Roche Pharmaceutical composition containing a glucosidase inhibitor and a lipase inhibitor
JP3532999B2 (ja) * 1995-03-24 2004-05-31 株式会社ロッテ 新規なタンニン類およびこれを有効成分とするリパーゼ阻害剤
JPH09227398A (ja) * 1996-02-20 1997-09-02 Zeria Pharmaceut Co Ltd 抗肥満剤
BR9807655A (pt) * 1997-02-05 2000-02-15 Hoffmann La Roche Uso de inibidores de lipase gastrintestinal.
US6004996A (en) * 1997-02-05 1999-12-21 Hoffman-La Roche Inc. Tetrahydrolipstatin containing compositions

Also Published As

Publication number Publication date
CZ265199A3 (cs) 2000-02-16
KR20000070733A (ko) 2000-11-25
NO324452B1 (no) 2007-10-22
IL131007A0 (en) 2001-01-28
HK1025251A1 (en) 2000-11-10
PL191222B1 (pl) 2006-03-31
NZ336755A (en) 2001-06-29
YU34199A (sh) 2002-08-12
EP1017408B1 (en) 2005-04-13
ATE292975T1 (de) 2005-04-15
NO993717D0 (no) 1999-07-30
PL334975A1 (en) 2000-03-27
BR9807655A (pt) 2000-02-15
EP1017408A1 (en) 2000-07-12
KR100479968B1 (ko) 2005-03-30
DE69829763T2 (de) 2006-04-13
DK1017408T3 (da) 2005-08-01
TR199901853T2 (xx) 1999-12-21
ZA98753B (en) 1998-08-05
DE69829763D1 (de) 2005-05-19
CN1246798A (zh) 2000-03-08
ES2239799T3 (es) 2005-10-01
AU6616998A (en) 1998-08-26
PT1017408E (pt) 2005-07-29
CN1154505C (zh) 2004-06-23
CA2278854C (en) 2014-03-04
AR011106A1 (es) 2000-08-02
AU740375B2 (en) 2001-11-01
WO1998034630A1 (en) 1998-08-13
RU2201272C2 (ru) 2003-03-27
NO993717L (no) 1999-10-04
JP2001509173A (ja) 2001-07-10
ID22650A (id) 1999-12-02
US6147108A (en) 2000-11-14
CA2278854A1 (en) 1998-08-13
HU230834B1 (hu) 2018-07-30
HUP0001014A3 (en) 2000-12-28
CZ295567B6 (cs) 2005-08-17
HUP0001014A2 (hu) 2000-08-28

Similar Documents

Publication Publication Date Title
NO992907D0 (no) Flat legemiddeltilberedning for applikasjon og frigiving av buprenorfin eller et annet farmakologisk sammenlignbart stoff i munnhulen og fremgangsmÕte for dens fremstilling
MY180762A (en) Combination therapy comprising glucose reabsorption inhibitors and ppar modulators.
DE60121988D1 (de) Kombinationstherapie mit antidiabetischen und antikonvulsiven mitteln
EE200300212A (et) Ravimite kombinatsioonid (näiteks kloorpromasiin ja pentamidiin) neoplastiliste haiguste raviks
NO20006630D0 (no) Farmasöytisk sammensetning for behandlingen av diabetes
TR199901853T2 (xx) Gastrointestinal lipaz inhibit�r�n�n kullan�lmas�.
NO20063000L (no) Kombinasjon og farmasøytisk blanding for behandling av diabetes samt anvendelse derav.
NL300258I1 (nl) Farmaceutische samenstelling voor toepassing in debehandeling van diabetes.
ZA200200738B (en) Use of monoamine oxidase inhibitors for the manufacture of drugs intended for the treatment of obesity.
AU2386201A (en) Substituted sapogenins and their use
DK0758241T3 (da) Anvendelse af visse methanbisphosphonsyrederivater til at hindre løsning og vandring af proteser
FI972308A0 (fi) 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
EP1072273A4 (en) VASKULARISIERUNGSINHIBITOREN
ATE400577T1 (de) Anellierte dihydropyrane
EP1295609A4 (en) MEDICINES WITH MIXED ACTIVE SUBSTANCES
BR9711306A (pt) Amino a-Úcar citotÄxico e derivados de a-Úcar correlatos de indolopirrolocarbazÄis
DE69531098D1 (de) Piperidine und pyrrolidine
DE59813162D1 (de) Pharmazeutische zusammensetzung enthaltend clindamycin und clotrimazol, zur behandlung vaginaler infektionen
ATE275966T1 (de) Activin stimulator enthaltende pharmazeutische zusammensetzung
EE9900450A (et) Tetrahüdropüridoühendid, neid sisaldav ravim ja nende kasutamine
HUP9802423A2 (hu) Hiperproliferatív megbetegedések kombinált gyógyászati kezelése
GB9907571D0 (en) Compounds
NO20014081L (no) Anvendelse av tianeptin i produksjonen av medikamenter til behandling av nevrodegenerative patologier
AP2001002369A0 (en) Pharmaceutical complex.
NO20020914L (no) Alkoksy-substituerte benzimidazolforbindelser, preparater inneholdende slike samt anvendelser derav